Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Recent Insights into the HIV/AIDS Pandemic.

Becerra JC, Bildstein LS, Gach JS.

Microb Cell. 2016 Sep 5;3(9):451-475. doi: 10.15698/mic2016.09.529. Review.

2.

Occupational Respiratory Diseases of Miners from Two Gold Mines in Ghana.

Ayaaba E, Li Y, Yuan J, Ni C.

Int J Environ Res Public Health. 2017 Mar 22;14(3). pii: E337. doi: 10.3390/ijerph14030337.

3.

Selective reduction of IFN-γ single positive mycobacteria-specific CD4+ T cells in HIV-1 infected individuals with latent tuberculosis infection.

Riou C, Bunjun R, Müller TL, Kiravu A, Ginbot Z, Oni T, Goliath R, Wilkinson RJ, Burgers WA.

Tuberculosis (Edinb). 2016 Dec;101:25-30. doi: 10.1016/j.tube.2016.07.018. Epub 2016 Aug 9.

4.

Impact of Infection Control Measures to Control an Outbreak of Multidrug-Resistant Tuberculosis in a Human Immunodeficiency Virus Ward, Peru.

Ticona E, Huaroto L, Kirwan DE, Chumpitaz M, Munayco CV, Maguiña M, Tovar MA, Evans CA, Escombe R, Gilman RH.

Am J Trop Med Hyg. 2016 Dec 7;95(6):1247-1256. Epub 2016 Sep 12.

5.

Tuberculosis Therapy Modifies the Cytokine Profile, Maturation State, and Expression of Inhibitory Molecules on Mycobacterium tuberculosis-Specific CD4+ T-Cells.

Saharia KK, Petrovas C, Ferrando-Martinez S, Leal M, Luque R, Ive P, Luetkemeyer A, Havlir D, Koup RA.

PLoS One. 2016 Jul 1;11(7):e0158262. doi: 10.1371/journal.pone.0158262. eCollection 2016.

6.

The incidence of tuberculosis among hiv-positive individuals with high CD4 counts: implications for policy.

Kufa T, Chihota V, Mngomezulu V, Charalambous S, Verver S, Churchyard G, Borgdorff M.

BMC Infect Dis. 2016 Jun 10;16:266. doi: 10.1186/s12879-016-1598-8.

7.

Sequential Dysfunction and Progressive Depletion of Candida albicans-Specific CD4 T Cell Response in HIV-1 Infection.

Liu F, Fan X, Auclair S, Ferguson M, Sun J, Soong L, Hou W, Redfield RR, Birx DL, Ratto-Kim S, Robb ML, Kim JH, Michael NL, Hu H.

PLoS Pathog. 2016 Jun 9;12(6):e1005663. doi: 10.1371/journal.ppat.1005663. eCollection 2016 Jun.

8.

Diagnostics for pulmonary tuberculosis.

Cudahy P, Shenoi SV.

Postgrad Med J. 2016 Apr;92(1086):187-93. doi: 10.1136/postgradmedj-2015-133278. Review.

9.

In Vivo Molecular Dissection of the Effects of HIV-1 in Active Tuberculosis.

Bell LC, Pollara G, Pascoe M, Tomlinson GS, Lehloenya RJ, Roe J, Meldau R, Miller RF, Ramsay A, Chain BM, Dheda K, Noursadeghi M.

PLoS Pathog. 2016 Mar 17;12(3):e1005469. doi: 10.1371/journal.ppat.1005469. eCollection 2016 Mar.

10.

HIV Skews the Lineage-Defining Transcriptional Profile of Mycobacterium tuberculosis-Specific CD4+ T Cells.

Riou C, Strickland N, Soares AP, Corleis B, Kwon DS, Wherry EJ, Wilkinson RJ, Burgers WA.

J Immunol. 2016 Apr 1;196(7):3006-18. doi: 10.4049/jimmunol.1502094. Epub 2016 Feb 29.

11.

PD-1 Expression and Cytokine Secretion Profiles of Mycobacterium tuberculosis-Specific CD4+ T-Cell Subsets; Potential Correlates of Containment in HIV-TB Co-Infection.

Pollock KM, Montamat-Sicotte DJ, Grass L, Cooke GS, Kapembwa MS, Kon OM, Sampson RD, Taylor GP, Lalvani A.

PLoS One. 2016 Jan 12;11(1):e0146905. doi: 10.1371/journal.pone.0146905. eCollection 2016.

12.

Differences in antigen-specific CD4+ responses to opportunistic infections in HIV infection.

Pollock KM, Montamat-Sicotte DJ, Cooke GS, Kapembwa MS, Kon OM, Grass L, Sampson RD, Taylor GP, Lalvani A.

Immun Inflamm Dis. 2015 Sep;3(3):141-53. doi: 10.1002/iid3.50. Epub 2015 Apr 29.

13.

Incidence of tuberculosis and immunological profile of TB/HIV co-infected patients in Nigeria.

Musa BM, Musa B, Muhammed H, Ibrahim N, Musa AG.

Ann Thorac Med. 2015 Jul-Sep;10(3):185-92. doi: 10.4103/1817-1737.160838.

14.

Molecular Analyses Define Vα7.2-Jα33+ MAIT Cell Depletion in HIV Infection: A Case-Control Study.

Ussher JE, Phalora P, Cosgrove C, Hannaway RF, Rauch A, Günthard HF, Goulder P, Phillips RE, Willberg CB, Klenerman P.

Medicine (Baltimore). 2015 Jul;94(29):e1134. doi: 10.1097/MD.0000000000001134.

15.

Restoration of CD4+ Responses to Copathogens in HIV-Infected Individuals on Antiretroviral Therapy Is Dependent on T Cell Memory Phenotype.

Riou C, Tanko RF, Soares AP, Masson L, Werner L, Garrett NJ, Samsunder N, Abdool Karim Q, Abdool Karim SS, Burgers WA.

J Immunol. 2015 Sep 1;195(5):2273-81. doi: 10.4049/jimmunol.1500803. Epub 2015 Jul 20.

16.

Excess Mortality Associated with Influenza among Tuberculosis Deaths in South Africa, 1999-2009.

Walaza S, Cohen C, Nanoo A, Cohen AL, McAnerney J, von Mollendorf C, Moyes J, Tempia S.

PLoS One. 2015 Jun 15;10(6):e0129173. doi: 10.1371/journal.pone.0129173. eCollection 2015.

17.

CD4+ T cell polyfunctional profile in HIV-TB coinfection are similar between individuals with latent and active TB infection.

Canaday DH, Sridaran S, Van Epps P, Aung H, Burant CJ, Nsereko M, Mayanja-Kizza H, Betts MR, Toossi Z.

Tuberculosis (Edinb). 2015 Jul;95(4):470-5. doi: 10.1016/j.tube.2014.12.008. Epub 2015 Jan 7.

18.

Attrition of TCR Vα7.2+ CD161++ MAIT cells in HIV-tuberculosis co-infection is associated with elevated levels of PD-1 expression.

Saeidi A, Tien Tien VL, Al-Batran R, Al-Darraji HA, Tan HY, Yong YK, Ponnampalavanar S, Barathan M, Rukumani DV, Ansari AW, Velu V, Kamarulzaman A, Larsson M, Shankar EM.

PLoS One. 2015 Apr 20;10(4):e0124659. doi: 10.1371/journal.pone.0124659. eCollection 2015.

19.

Do clinical decision-support reminders for medical providers improve isoniazid preventative therapy prescription rates among HIV-positive adults? Study protocol for a randomized controlled trial.

Green EP, Catalani C, Diero L, Carter EJ, Gardner A, Ndwiga C, Keny A, Owiti P, Israelski D, Biondich P.

Trials. 2015 Apr 9;16:141. doi: 10.1186/s13063-015-0558-8.

20.

Persistent high mortality in advanced HIV/TB despite appropriate antiretroviral and antitubercular therapy: an emerging challenge.

Bisson GP, Zetola N, Collman RG.

Curr HIV/AIDS Rep. 2015 Mar;12(1):107-16. doi: 10.1007/s11904-015-0256-x. Review.

Supplemental Content

Support Center